WHAT ARE THE KEY DRIVERS FOR CHANGING HTA DECISIONS? EXAMPLE OF ALZHEIMER'S DISEASE TREATMENT IN GERMANY, FRANCE AND UK

被引：1
|
作者：
Ackermann, J. [1 ]
Toumi, M. [2 ]
机构：
[1] Creativ Ceut, Paris, France
[2] Univ Lyon 1, F-69365 Lyon, France
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.528
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A329 / A329
页数：1
相关论文
共 50 条
  • [1] KEY DRIVERS OF HTA DECISIONS FOR "LIFE-CHANGING" DRUGS
    Jaksa, A.
    Peress, E.
    Viana, R.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A491 - A491
  • [2] WHAT INFLUENCES THE PROBABILITY TO BE SUCCESSFUL IN AN ONCOLOGY HTA? AN ANALYSIS OF ONCOLOGY HTA DECISIONS IN GERMANY, SPAIN AND THE UK
    Hardtstock, F.
    Kocaata, Z.
    Wilke, T.
    Rebollo, P.
    Garcia, A.
    Heeg, B.
    [J]. VALUE IN HEALTH, 2019, 22 : S410 - S410
  • [3] A COMPARISON OF HTA DECISIONS IN FRANCE AND GERMANY FOR NEW TREATMENT OPTIONS IN ONCOLOGY IN 2019
    Henry, A.
    Lionikaite, V
    von Wilamowitz-Moellendorff, C. M.
    Curry, A.
    Ralston, S.
    [J]. VALUE IN HEALTH, 2020, 23 : S68 - S68
  • [4] ONCOLOGY-RELATED HTA DECISIONS IN GERMANY, FRANCE, SPAIN AND THE UK: ASSESSMENT OF SIMILARITIES AND DIFFERENCES
    Hardtstock, F.
    Kocaata, Z.
    Wilke, T.
    Rebollo, P.
    Garcia, A.
    Heeg, B.
    [J]. VALUE IN HEALTH, 2019, 22 : S514 - S514
  • [5] LANDSCAPE ASSESSMENT AND KEY HTA CONSIDERATIONS IN ALZHEIMER'S DISEASE
    Takyar, S.
    Kaur, S.
    Takyar, J.
    Dhawan, A.
    [J]. VALUE IN HEALTH, 2019, 22 : S752 - S752
  • [6] IMPACT OF MEDICAL DEVICE REGULATION ON FUTURE HTA'S AND REIMBURSEMENT DECISIONS IN GERMANY, FRANCE AND SWITZERLAND - WHAT IS BLOOMING HERE?
    Droschel, D.
    Koerber, F.
    Timmermans, V
    Lebourgeois, C.
    Wagner, N.
    Schulze, K.
    [J]. VALUE IN HEALTH, 2018, 21 : S273 - S273
  • [7] HOW WAS THE SOCIETAL PERSPECTIVE ADDRESSED IN HTA DECISIONS ABOUT ALZHEIMER'S DISEASE?
    Torres, L.
    Martins, J.
    Kashiura, D.
    Oesterreicher, B.
    Lemos, L.
    Lima, P.
    Kano, B.
    Meirelles, I
    Julian, G.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S185 - S185
  • [8] What is a genetic cause? The example of Alzheimer's Disease
    Dekkers W.
    Rikkert M.O.
    [J]. Medicine, Health Care and Philosophy, 2006, 9 (3) : 273 - 284
  • [9] HTA REVIEW OF DECISIONS FOR PRODUCTS INDICATED IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) AND LUPUS NEPHRITIS (N) IN UK, GERMANY, FRANCE, ITALY, SPAIN, CANADA AND TURKEY
    Ulger, F. M.
    Kockaya, G.
    [J]. VALUE IN HEALTH, 2019, 22 : S907 - S907
  • [10] Sex specific molecular networks and key drivers of Alzheimer's disease
    Guo, Lei
    Cao, Jiqing
    Hou, Jianwei
    Li, Yonghe
    Huang, Min
    Zhu, Li
    Zhang, Larry
    Lee, Yeji
    Duarte, Mariana Lemos
    Zhou, Xianxiao
    Wang, Minghui
    Liu, Chia-Chen
    Martens, Yuka
    Chao, Michael
    Goate, Alison
    Bu, Guojun
    Haroutunian, Vahram
    Cai, Dongming
    Zhang, Bin
    [J]. MOLECULAR NEURODEGENERATION, 2023, 18 (01)
12345